CMS Proposes Medicare Coverage for Renal Denervation to Address Uncontrolled Hypertension

The Centers for Medicare & Medicaid Services (CMS) has proposed national Medicare coverage for renal denervation, a device-based treatment aimed at addressing uncontrolled hypertension. This development could benefit companies such as Medtronic and ReCor Medical, which have developed technologies in this area. The proposal marks a significant step toward expanding access to innovative treatments for patients struggling with high blood pressure that remains resistant to conventional therapies.

Renal denervation is a minimally invasive procedure that targets overactive nerves in the kidneys, which are believed to contribute to elevated blood pressure. Medtronic and ReCor Medical have been at the forefront of developing devices designed for this purpose. If approved, the CMS coverage would make these treatments more accessible to Medicare beneficiaries nationwide. The proposal reflects growing interest in alternative approaches to managing hypertension, particularly for patients who do not respond adequately to medication or lifestyle changes. Further details on the proposal and its implications can be found on Medtech Dive’s website.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: July 14, 2025

Author

Mark Chiang